Page 35 - AN-4-2

Advanced Neurology SARS-CoV-2 mechanisms of neurological impact

autopsy. Nature. 2022;612(7941):758‑763. 16. Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in
people with covid-19: Cohort study. BMJ. 2022;376:e068993.
doi: 10.1038/s41586-022-05542-y
doi: 10.1136/bmj‑2021‑068993
6. Taquet M, Sillett R, Zhu L, et al. Neurological and psychiatric
risk trajectories after SARS‑CoV‑2 infection: An analysis 17. Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of
of 2-year retrospective cohort studies including 1 284 COVID-19. Nat Med. 2022;28(11):2406‑2415.
437 patients. Lancet Psychiatry. 2022;9(10):815‑827.
doi: 10.1038/s41591-022-02001-z
doi: 10.1016/S2215-0366(22)00260-7 18. Amraei R, Xia C, Olejnik J, et al. Extracellular vimentin is
7. Pandharipande P, Williams Roberson S, Harrison FE, an attachment factor that facilitates SARS-CoV-2 entry
Wilson JE, Bastarache JA, Ely EW. Mitigating neurological, into human endothelial cells. Proc Natl Acad Sci U S A.
cognitive, and psychiatric sequelae of COVID-19-related 2022;119(6):e2113874119.
critical illness. Lancet Respir Med. 2023;11(8):726‑738. doi: 10.1073/pnas.2113874119
doi: 10.1016/S2213-2600(23)00238-2 19. Cantuti‑Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1
8. Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization facilitates SARS-CoV-2 cell entry and infectivity. Science.
of post-acute sequelae of COVID-19. Nature. 2020;370(6518):856‑860.
2021;594(7862):259‑264. doi: 10.1126/science.abd2985
doi: 10.1038/s41586-021-03553-9 20. Hoffmann M, Kleine‑Weber H, Schroeder S, et al. SARS-
9. Liu TC, Yoo SM, Sim MS, Motwani Y, Viswanathan N, CoV-2 cell entry depends on ACE2 and TMPRSS2 and
Wenger NS. Perceived cognitive deficits in patients is blocked by a clinically proven protease inhibitor. Cell.
with symptomatic SARS-CoV-2 and their association 2020;181(2):271‑280.e8.
with post-COVID-19 condition. JAMA Netw Open. doi: 10.1016/j.cell.2020.02.052
2023;6(5):e2311974.
21. Lersy F, Benotmane I, Helms J, et al. Cerebrospinal fluid
doi: 10.1001/jamanetworkopen.2023.11974 features in patients with coronavirus disease 2019 and
10. Hartung TJ, Neumann C, Bahmer T, et al. Fatigue and neurological manifestations: Correlation with brain
cognitive impairment after COVID-19: A prospective magnetic resonance imaging findings in 58 patients. J Infect
multicentre study. EClinicalMedicine. 2022;53:101651. Dis. 2021;223(4):600‑609.

doi: 10.1016/j.eclinm.2022.101651 doi: 10.1093/infdis/jiaa745
11. Zhao S, Martin EM, Reuken PA, et al. Long COVID is 22. Schweitzer F, Goereci Y, Franke C, et al. Cerebrospinal
associated with severe cognitive slowing: A multicentre fluid analysis post-COVID-19 is not suggestive of
cross-sectional study. EClinicalMedicine. 2024;68:102434. persistent central nervous system infection. Ann Neurol.
2022;91(1):150‑157.
doi: 10.1016/j.eclinm.2024.102434
doi: 10.1002/ana.26262
12. Hampshire A, Azor A, Atchison C, et al. Cognition and
memory after Covid-19 in a large community sample. 23. Yang AC, Kern F, Losada PM, et al. Dysregulation of brain
N Engl J Med. 2024;390(9):806‑818. and choroid plexus cell types in severe COVID-19. Nature.
2021;595(7868):565‑571.
doi: 10.1056/NEJMoa2311330
doi: 10.1038/s41586-021-03710-0
13. Becker JH, Lin JJ, Doernberg M, et al. Assessment of
cognitive function in patients after COVID-19 infection. 24. Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is
JAMA Netw Open. 2021;4(10):e2130645. associated with changes in brain structure in UK Biobank.
Nature. 2022;604(7907):697‑707.
doi: 10.1001/jamanetworkopen.2021.30645
doi: 10.1038/s41586-022-04569-5
14. Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ.
6-month neurological and psychiatric outcomes in 236 379 25. Monje M, Iwasaki A. The neurobiology of long COVID.
survivors of COVID-19: A retrospective cohort study using Neuron. 2022;110(21):3484‑3496.
electronic health records. Lancet Psychiatry. 2021;8(5):416‑427. doi: 10.1016/j.neuron.2022.10.006
doi: 10.1016/S2215-0366(21)00084-5 26. Wong AC, Devason AS, Umana IC, et al. Serotonin
reduction in post-acute sequelae of viral infection. Cell.
15. Bohmwald K, Galvez NMS, Rios M, Kalergis AM.
Neurologic alterations due to respiratory virus infections. 2023;186(22):4851‑4867.e20.
Front Cell Neurosci. 2018;12:386. doi: 10.1016/j.cell.2023.09.013
doi: 10.3389/fncel.2018.00386 27. Moghimi N, Di Napoli M, Biller J, et al. The neurological

Volume 4 Issue 2 (2025) 29 doi: 10.36922/an.4909